These findings not only highlight the importance of glutamine deprivation in reducing the proliferative activity of glioblastomas, but also suggest that the Gln/Glu ratio and the related expression of xCT/ZEB1 are potential molecular markers for more aggressive subtypes of glioblastoma. Here, SLC7A11 is linked to glioblastoma.